Altogether, our results indicate that the levels of TROLL-2 and TROLL-3 and the cytoplasmic location of WDR26 are markers of cancer progression in several human tumour types, and that these factors are prognostic in melanoma. This evidence concerns the gene WDR26 and neoplasm.